Company Hansoh Pharmaceutical Group Company Limited OTC Markets
Equities
HNSPF
KYG549581067
Pharmaceuticals
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.88 USD | +19.75% | -.--% | +2.73% |
Apr. 29 | Hansoh Pharmaceutical Group Company Limited Announces Executive Changes, Effective April 29, 2024 | CI |
Apr. 03 | Hansoh Pharmaceutical Secures Chinese Nod for Trial of Anti-Cancer Drug | MT |
Business Summary
- sales of pharmaceutical products (99.1%);
- sales of research and development services (0.9%).
Number of employees: 9,123
Sales per Business
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Oncology
61.1
%
| 6,421 | 58.9 % | 6,817 | 61.1 % | +6.16% |
Central Nervous System Diseases
13.5
%
| 1,737 | 15.9 % | 1,511 | 13.5 % | -13.05% |
Metabolic Diseases and Others
12.9
%
| 1,299 | 11.9 % | 1,435 | 12.9 % | +10.51% |
Anti-infective Diseases
12.6
%
| 1,452 | 13.3 % | 1,402 | 12.6 % | -3.46% |
Sales per region
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 10,911 | 100.0 % | 11,165 | 100.0 % | +2.33% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Hui Juan Zhong
CEO | Chief Executive Officer | 63 | 15-12-01 |
Sheng Li Zhong
SEC | Corporate Secretary | 56 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Guo Qiang Lin
BRD | Director/Board Member | 81 | 19-05-30 |
Sheung Wai Chan
BRD | Director/Board Member | 70 | 19-06-13 |
Dong Tao Yang
BRD | Director/Board Member | 67 | - |
Hui Juan Zhong
CEO | Chief Executive Officer | 63 | 15-12-01 |
Ai Feng Lyu
BRD | Director/Board Member | 47 | 16-03-10 |
Yu An Sun
BRD | Director/Board Member | 38 | 15-12-01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 5,945,264,770 | 1,084,286,470 ( 18.24 %) | 9,614,700 ( 0.1617 %) | 18.24 % |
Company contact information
Hansoh Pharmaceutical Group Co., Ltd.
287 Xiangke Road Pudong New District
201210, Shanghai
+
http://www.hspharm.comSector
Sales per Business
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+38.59% | 727B | |
-7.89% | 354B | |
+15.66% | 328B | |
+0.24% | 277B | |
+13.47% | 243B | |
+7.35% | 205B | |
-6.42% | 203B | |
+4.23% | 164B | |
-1.70% | 164B |
- Stock Market
- Equities
- 3692 Stock
- HNSPF Stock
- Company Hansoh Pharmaceutical Group Company Limited